Ontology highlight
ABSTRACT:
SUBMITTER: Garg G
PROVIDER: S-EPMC4329597 | biostudies-literature | 2015 Feb
REPOSITORIES: biostudies-literature
ACS medicinal chemistry letters 20141212 2
Hsp90 C-terminal inhibitors represent a novel and alternative chemotherapeutic approach for the treatment of cancer. Novobiocin was the first natural product identified as an Hsp90 C-terminal inhibitor; however, it manifests poor antiproliferative activity. In contrast to N-terminal inhibitors, novobiocin does not induce the pro-survival heat shock response. Structural investigations on novobiocin have elucidated some structure-activity relationships and several promising compounds. On the basis ...[more]